Cargando…

The tumor suppressor CDKN3 controls mitosis

Mostrar otras versiones (1)

Mitosis is controlled by a network of kinases and phosphatases. We screened a library of small interfering RNAs against a genome-wide set of phosphatases to comprehensively evaluate the role of human phosphatases in mitosis. We found four candidate spindle checkpoint phosphatases, including the tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalepa, Grzegorz, Barnholtz-Sloan, Jill, Enzor, Rikki, Dey, Dilip, He, Ying, Gehlhausen, Jeff R., Lehmann, Amalia S., Park, Su-Jung, Yang, Yanzhu, Yang, Xianlin, Chen, Shi, Guan, Xiaowei, Chen, Yanwen, Renbarger, Jamie, Yang, Feng-Chun, Parada, Luis F., Clapp, Wade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2013
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691455/ https://www.ncbi.nlm.nih.gov/pubmed/23775190 http://dx.doi.org/10.1083/jcb.201205125

Ejemplares similares

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

INPP5E Preserves Genomic Stability through Regulation of Mitosis
por: Sierra Potchanant, Elizabeth A., et al.
Publicado: (2017)

Fanconi anemia and the cell cycle: new perspectives on aneuploidy
por: Nalepa, Grzegorz, et al.
Publicado: (2014)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

A Critical Role of CDKN3 in Bcr-Abl-Mediated Tumorigenesis
por: Chen, Qinghuang, et al.
Publicado: (2014)

Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx
por: Chernock, Rebecca D., et al.
Publicado: (2012)

Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance
por: Yang, Chenlong, et al.
Publicado: (2020)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
por: Zhu, Changyu, et al.
Publicado: (2023)

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)

Nuclear envelope remodelling during mitosis
por: Dey, Gautam, et al.
Publicado: (2021)

CDKN1C/p57(kip2 )is a candidate tumor suppressor gene in human breast cancer
por: Larson, Pamela S, et al.
Publicado: (2008)

The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1
por: Wu, Xiaohua, et al.
Publicado: (2011)

Splitting random forest (SRF) for determining compact sets of genes that distinguish between cancer subtypes
por: Guan, Xiaowei, et al.
Publicado: (2012)

Computational identification of multi-omic correlates of anticancer therapeutic response
por: Stetson, Lindsay C, et al.
Publicado: (2014)

Erratum: Computational identification of multi-omic correlates of anticancer therapeutic response
por: Stetson, Lindsay C, et al.
Publicado: (2015)

Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant
por: Tramontana, Timothy F., et al.
Publicado: (2020)

CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3
por: Yang, Lei, et al.
Publicado: (2022)

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
por: Minervini, Giovanni, et al.
Publicado: (2017)

Mammalian cell growth dynamics in mitosis
por: Miettinen, Teemu P, et al.
Publicado: (2019)

Committing to mitosis
por: Wells, William A.
Publicado: (2003)

Integrins for mitosis
por: LeBrasseur, Nicole
Publicado: (2006)

The Cell in Mitosis
por: Lubs, Herbert A.
Publicado: (1964)

Mitosis is swell
por: Zatulovskiy, Evgeny, et al.
Publicado: (2015)

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
por: Algar, Elizabeth M., et al.
Publicado: (2009)

A Required Ophthalmology Rotation: Providing Medical Students with a Foundation in Eye-Related Diagnoses and Management
por: Bowers, Eve M.R., et al.
Publicado: (2021)

Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study
por: Lehmann, Amalia S, et al.
Publicado: (2013)

Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui, Xiaopeng, et al.
Publicado: (2021)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis
por: Xia, Yong, et al.
Publicado: (2021)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer
por: Wildey, Gary, et al.
Publicado: (2014)

Methylation Analysis of Several Tumour Suppressor Genes Shows a Low Frequency of Methylation of CDKN2A and RARB in Uveal Melanomas
por: Zeschnigk, Michael, et al.
Publicado: (2003)

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
por: Ingram, David A., et al.
Publicado: (2000)

Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
por: Wu, Chu, et al.
Publicado: (2020)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

Astrin: A Key Player in Mitosis and Cancer
por: Ying, Zhenguang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s36qpah2e9h8trvr8aatd8rj7o